HRASLS3 Activators
HRASLS3 Activators consists of a diverse array of chemical compounds that interact with various cellular pathways, leading to the modulation of HRASLS3 activity. These activators do not bind directly to the protein but exert their influence indirectly through cellular signaling pathways and processes. For instance, compounds like Retinoic acid and Epigallocatechin gallate (EGCG) can affect gene expression and lipid metabolism, pathways in which HRASLS3 is a component. Retinoic acid is particularly known for its role in cellular differentiation, which may increase the expression of HRASLS3, while EGCG influences lipid metabolism, an area where HRASLS3 also functions.
Other molecules such as Dibutyryl cAMP and Phorbol 12-myristate 13-acetate (PMA) act on enzymes like protein kinase A (PKA) and protein kinase C (PKC), which are central to signal transduction pathways that could impinge upon HRASLS3 function. Similarly, lipid molecules like Sphingosine-1-phosphate and Oleic acid can be part of signaling cascades or serve as substrates that influence HRASLS3's activity in lipid metabolism. Sodium butyrate represents an epigenetic angle, as it can lead to the expression of proteins by modifying chromatin structure. Finally, inhibitors like LY294002 act on phosphoinositide 3-kinases (PI3K), which are upstream of multiple signaling pathways that might regulate HRASLS3
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that can regulate gene expression and may increase HRASLS3 expression as part of differentiation signals. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A catechin found in green tea that may modulate lipid metabolism and influence proteins involved in these pathways, like HRASLS3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
A glycogen synthase kinase 3 (GSK3) inhibitor that may enhance signaling pathways affecting HRASLS3 activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPARγ agonist that could upregulate HRASLS3 expression by influencing lipid metabolism and adipocyte differentiation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can activate PKA and potentially increase HRASLS3 activity through phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator that can modulate signal transduction pathways, possibly influencing HRASLS3 activity. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that might affect lipid metabolism and signaling pathways associated with HRASLS3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
A bioactive lipid that can activate signaling pathways, potentially influencing HRASLS3 activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
A fatty acid that could be a substrate for HRASLS3 and might indirectly activate its enzymatic function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that may enhance HRASLS3 expression through epigenetic modulation. | ||||||